The Emirates Dermatology Society, EDS, and Novartis have launched 'Skin To Live In', an awareness campaign bringing hope and inspiration to people living with psoriasis, one of the world's most prevalent autoimmune skin disorders, and creating greater public awareness.
Dr. Anwar Al Hammadi, President of EDS, said, "Psoriasis is a common, non-contagious, autoimmune disease that affects about one adult in 50, or 125 million people worldwide, making it one of the most common autoimmune skin disorders."
He added, "It is not simply a cosmetic problem, but a persistent, chronic condition caused by skin cells multiplying up to 10 times faster than normal. Their sheer volume results in red, scaly patches that can lead to pain, discomfort and even psychological problems that can severely impact patients' lives."
Mohamed EzzEldin, Head of the Gulf Cluster at Novartis Pharmaceuticals, said, "Psoriasis is a common, yet often misunderstood condition. We are very proud to launch 'Skin to Live In', and we thank our partners at EDS whose valuable collaboration has made this a truly all-encompassing endeavor, harnessing stakeholder efforts to inspire patients to break free from the challenges of living with psoriasis."